CSL expands public reimbursement for ANDEMBRY in Quebec and Alberta
CSL said ANDEMBRY (garadacimab) now has public reimbursement in Quebec and Alberta, plus coverage via federal NIHB and Veterans Affairs Canada for eligible HAE patients.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.